StockData
Legend Biotech Corp logo

Legend Biotech Corp (LEGN) stock

LEGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 10, 2026Score 3/30
$16.11+0.12 (+0.75%)

Close on Nov 17, 2026Market cap $2.98BP/E –Yield –

Legend Biotech enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Legend Biotech's enterprise value was $3.14B on Nov 11, 2026, against $5.13B a year earlier. Over the last 5 years it ranged from $2.75B to $11.49B, with a median of $6.42B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.14B-22.2%
2025Dec 31, 2025$4.04B-30.1%
2024Dec 31, 2024$5.77B-40.2%
2023Dec 29, 2023$9.65B+49.4%
2022Dec 30, 2022$6.46B+28.3%
2021Dec 31, 2021$5.04B+84.3%
2020Dec 31, 2020$2.73B–

More Legend Biotech figures

See a number that looks wrong?